TPD52 and prostate cancer: Consistent with these data, phosphorylation of Chk2, which localized downstream of DNA-PKcs and ATM kinases and was important to DNA damage-induced cell cycle checkpoint activation, was also enhanced in PC-1/PrLZ deficient prostate cancer cells.